28 reports of this reaction
2.7% of all FERROSOFERRIC PHOSPHATE reports
#5 most reported adverse reaction
NAUSEA is the #5 most commonly reported adverse reaction for FERROSOFERRIC PHOSPHATE, manufactured by DNA Labs. There are 28 FDA adverse event reports linking FERROSOFERRIC PHOSPHATE to NAUSEA. This represents approximately 2.7% of all 1,043 adverse event reports for this drug.
Patients taking FERROSOFERRIC PHOSPHATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for FERROSOFERRIC PHOSPHATE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for FERROSOFERRIC PHOSPHATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 28 FDA reports for FERROSOFERRIC PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.7% of all adverse event reports for FERROSOFERRIC PHOSPHATE, making it a notable side effect.
If you experience nausea while taking FERROSOFERRIC PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.